Switzerland’s Roche has halted a trial of its experimental type-2 diabetes drug taspoglutide in order to analyze its more disturbing side effects (more…)
Devices & Medicine
Next Page »« Previous PageMajor Setback for Roche’s Type-2 Drug
Monday, September 13th, 2010 by Chris FrankieStudy Isolates Type 1 Trigger Genes
Friday, September 10th, 2010 by Chris FrankieA team of international scientists has identified the genes that appear to trigger type 1 diabetes, raising the possibility of new treatments (more…)
Wait Nearly Over for Newest Type 2 Drug
Friday, September 10th, 2010 by Chris FrankieThe only type 2 diabetes drug approved since 2008 is set to start selling this fall (more…)
Production Stalled for Hot-Selling Monitor
Monday, August 30th, 2010 by Chris FrankieThe maker of wrist-watch-like sugar monitor Diabetes Sentry is having trouble financing its next round of production, despite having up to 400 pending orders (more…)
Glucose Monitor Probes with Light, Not Sticks
Wednesday, August 11th, 2010 by Chris FrankieResearchers at the Massachusetts Institute of Technology are developing a device that monitors glucose using light pulses rather than finger pricks. (more…)
FDA Approval for ‘Coaching’ Device
Wednesday, August 4th, 2010 by Chris FrankieA newly FDA-approved mobile diabetes monitor will be the first to deliver real-time clinical feedback based on the user’s input. (more…)
Giant Eagle Offering Free Type 2 Medications
Wednesday, July 28th, 2010 by Chris FrankieGiant Eagle is among the growing number of supermarkets and pharmacies providing free common Type 2 diabetes drugs to customers (more…)
Top New Diabetes Tech Ideas: DiabetesMine Awards
Friday, June 11th, 2010 by Chris FrankieDiabetesMine, a blog for people with diabetes with a slant towards technology, announced the winners of its 2010 DiabetesMine Design Challenge. The annual web-based competition, which is open to anyone, aims to foster innovation in diabetes design and encourage creative new tools to improve the lives of people with diabetes. (more…)
FDA Probes Link Between Type 2 Deaths, Blood Pressure Meds
Friday, June 11th, 2010 by Chris FrankieThe U.S. Food and Drug Administration (FDA) is examining data from two clinical trials to determine whether Benicar, a blood pressure medicine, increases the risk of heart-related deaths in Type 2 diabetic patients (more…)
Diabetes News Hound Categories
- Devices & Medicine
- Diabetes 101
- Diabetes in Pop Culture
- Diet Digest
- Doctor Ratings
- Gestational Diabetes
- Living with a Diabetic
- Newly Diagnosed
- Pre Diabetes
- Research & Cure
- Type 1 Diabetes
- Type 1.5 (LADA) Diabetes
- Type 2 Diabetes
- Uncategorized
- Video